Why Dermata Therapeutics Took Off After-Hours Unlocking New Value: Dermata Therapeutics Sees After-Hours Surge
Breaking News Dermata Therapeutics, Inc. DRMAW has experienced a notable surge in after-hours trading following the company’s announcement of a newly issued patent in Japan for its DMT410 program, which targets the treatment of hyperhidrosis. Key Developments The issuance of the patent, the first for …